Anvisa Approves Generic Medicines Against Diabetes and Obesity

Globo

Lean Right

Factuality

Ownership

Freepik The National Agency for Health Surveillance (Anvisa) approved two new generic liraglutide-based medicines, an active principle used in pens for the treatment of obesity and type 2 diabetes. The authorisations were granted to the Brazilian pharmacist EMS. The products will have a concentration of 6 mg/mL, in solution for injection of subcutaneous application. The two pens are linked to medicines that EMS itself already markets: Olire, ind…

O Cafezinho

Factuality

Ownership

Records allow two liraglutide 6 mg/mL pens to be sold by the active principle name to treat obesity and type 2 diabetes.

É ASSIM

Factuality

Ownership

Medicines are generic of liraglutide and may cost 35% less

Poder360

Factuality

Ownership

Semaglutida gained generics, while liraglutida had 2 new versions approved by Anvisa on 3rd Friday. Read on Power360.

EBC

Agora RN

View article

Reposted by

Agora RN

Factuality

Ownership

The National Agency for Health Surveillance (Anvisa) approved the records of two generic drugs based on liraglutide. The substance is used in pens to treat obesity and type 2 diabetes. Both will have a concentration of 6 mg/mL. The authorizations were granted to the Brazilian pharmacist EMS and published on Tuesday (8) in the Official Journal of the Union. The company already markets two pens with the medicines: Olire, focused on weight control …

tribunadonorte.com.br

Factuality

Ownership

The National Agency of Health Surveillance (Anvisa) approved the records of two generic drugs based on liraglutide. The substance is used in pens to treat obesity and type 2 diabetes. Both will have a concentration of 6 mg/mL. The authorizations were granted to the Brazilian pharmacist EMS and published on Tuesday (8) in the Official Journal of the Union. The company already sells [...] The post Anvisa approves generic medicines against diabetes…